{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T18:53:22Z","timestamp":1676660002312},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T00:00:00Z","timestamp":1194998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s00393-007-0226-9","type":"journal-article","created":{"date-parts":[[2007,11,12]],"date-time":"2007-11-12T05:46:51Z","timestamp":1194846411000},"page":"686-692","source":"Crossref","is-referenced-by-count":4,"title":["Aktuelle Therapien der Dermatomyositis und Polymyositis"],"prefix":"10.1007","volume":"66","author":[{"given":"J.","family":"Richter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Iking-Konert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,14]]},"reference":[{"key":"226_CR1","first-page":"352","volume":"26","author":"Adams","year":"1999","unstructured":"Adams EM, Pucino F, Yarboro C et al. (1999) A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures. J Rheumatol 26: 352\u2013360","journal-title":"J Rheumatol"},{"key":"226_CR2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.bor.0000152665.41493.49","volume":"17","author":"Alexanderson","year":"2005","unstructured":"Alexanderson H, Lundberg IE (2005) The role of exercise in the rehabilitation of idiopathic inflammatory myopathies. Curr Opin Rheumatol 17: 164\u2013171","journal-title":"Curr Opin Rheumatol"},{"key":"226_CR3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00019052-200310000-00002","volume":"16","author":"Amato","year":"2003","unstructured":"Amato AA, Griggs RC (2003) Treatment of idiopathic inflammatory myopathies. Curr Opin Neurol 16: 569\u2013575","journal-title":"Curr Opin Neurol"},{"key":"226_CR4","doi-asserted-by":"crossref","unstructured":"Anandacoomarasamy A, Howe G, Manolios N (2005) Advanced refractory polymyositis responding to infliximab. Rheumatology (Oxford) 44: 562\u2013563","DOI":"10.1093\/rheumatology\/keh539"},{"key":"226_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344\u2013347","journal-title":"N Engl J Med"},{"key":"226_CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292: 403\u2013407","journal-title":"N Engl J Med"},{"key":"226_CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","volume":"92","author":"Bunch","year":"1980","unstructured":"Bunch TW, Worthington JW, Combs JJ et al. (1980) Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med 92: 365\u2013369","journal-title":"Ann Intern Med"},{"key":"226_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","volume":"24","author":"Bunch","year":"1981","unstructured":"Bunch TW (1981) Prednisone and azathioprine for polymyositis: long-term followup. Arthritis Rheum 24: 45\u201348","journal-title":"Arthritis Rheum"},{"key":"226_CR9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","volume":"65","author":"Bronner","year":"2006","unstructured":"Bronner IM, Meulen MF van der, Visser M de et al. (2006) Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 65: 1456\u20131461","journal-title":"Ann Rheum Dis"},{"key":"226_CR10","first-page":"658","volume":"9","author":"Cagnoli","year":"1991","unstructured":"Cagnoli M, Marchesoni A, Tosi S (1991) Combined steroid, methotrexate and chlorambucil therapy for steroid-resistant dermatomyositis. Clin Exp Rheumatol 9: 658\u2013659","journal-title":"Clin Exp Rheumatol"},{"key":"226_CR11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clindermatol.2006.07.001","volume":"24","author":"Callen","year":"2006","unstructured":"Callen JP, Wortmann RL (2006) Dermatomyositis. Clin Dermatol 24: 363\u2013373","journal-title":"Clin Dermatol"},{"key":"226_CR12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/art.10053","volume":"46","author":"Cherin","year":"2002","unstructured":"Cherin P, Pelletier S, Teixeira A et al. (2002) Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 46: 467\u2013474","journal-title":"Arthritis Rheum"},{"key":"226_CR13","first-page":"1092","volume":"21","author":"Cherin","year":"1994","unstructured":"Cherin P, Piette JC, Wechsler B et al. (1994) Intravenous gamma globulin as first line therapy in polymyositis a dermatomyositis: an open study in 11 adult patients. J Rheumatol 21: 1092\u20131097","journal-title":"J Rheumatol"},{"key":"226_CR14","first-page":"CD003643","volume":"20","author":"Choy","year":"2005","unstructured":"Choy EH, Hoogendijk JE, Lecky B, Winer JB (2005) Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 20: CD003643","journal-title":"Cochrane Database Syst Rev"},{"key":"226_CR15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","volume":"143","author":"Chung","year":"2007","unstructured":"Chung L, Genovese MC, Fiorentino DF (2007) A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch Dermatol 143: 763\u2013767","journal-title":"Arch Dermatol"},{"key":"226_CR16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/pgmj.2005.038455","volume":"82","author":"Cordeiro","year":"2006","unstructured":"Cordeiro AC, Isenberg DAN (2006) Treatment of inflammatory myopathies. Postgrad Med J 82: 417\u2013424","journal-title":"Postgrad Med J"},{"key":"226_CR17","unstructured":"Dachverband Osteologie (Hrsg) (2006) Evidenz-basierten Konsensus-Leitlinie zur Osteoporose bei chronischer Einnahme von Glukokortikoiden http:\/\/www.lutherhaus.de\/osteo\/leitlinien-dvo\/PDFs\/DVO-Leitlinie%20Glukokortikoid-Osteoporose%20Version%2006\u201309\u201307%20.pdf (Stand 01.10.2007)"},{"key":"226_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2005.12.008","volume":"16","author":"Dalakas","year":"2006","unstructured":"Dalakas MS (2006) Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord 16: 223\u2013236 [Epub Mar 15]","journal-title":"Neuromuscul Disord"},{"key":"226_CR19","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al. (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329: 1993\u2013200","journal-title":"N Engl J Med"},{"key":"226_CR20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/art.22996","volume":"57","author":"Dastmalchi","year":"2007","unstructured":"Dastmalchi M, Alexanderson H, Loell I et al. (2007) Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum 57: 1303\u20131310","journal-title":"Arthritis Rheum"},{"key":"226_CR21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s10067-006-0325-z","volume":"26","author":"Dold","year":"2007","unstructured":"Dold S, Justiniano ME, Marquez J, Espinoza LR (2007) Treatment of early and refractory dermatomyositis with infliximab: a report of two cases. Clin Rheumatol 26: 1186\u20131188","journal-title":"Clin Rheumatol"},{"key":"226_CR22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.semarthrit.2006.07.003","volume":"36","author":"Efthimiou","year":"2006","unstructured":"Efthimiou P (2006) Tumor necrosis factor-alpha in inflammatory myopathies: pathophysiology and therapeutic implications. Semin Arthritis Rheum 36: 168\u2013172","journal-title":"Semin Arthritis Rheum"},{"key":"226_CR23","first-page":"1542","volume":"27","author":"Gelber","year":"2000","unstructured":"Gelber AC, Nousari HC, Wigley FM (2000) Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases. J Rheumatol 27: 1542\u20131545","journal-title":"J Rheumatol"},{"key":"226_CR24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00108-005-1496-4","volume":"46","author":"Genth","year":"2005","unstructured":"Genth E (2005) Entz\u00fcndliche Muskelkrankheiten. Polymyositis, Dermatomyositis und Einschlussk\u00f6rpermyositis. Internist 46: 1218\u20131232","journal-title":"Internist"},{"key":"226_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000079547","volume":"52","author":"Hengstman","year":"2004","unstructured":"Hengstman GJ, Hoogen FH van den, Engelen BG van (2004) Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up. Eur Neurol 52: 61\u201363","journal-title":"Eur Neurol"},{"key":"226_CR26","first-page":"1802","volume":"33","author":"Iannone","year":"2006","unstructured":"Iannone F, Scioscia C, Falappone PC et al. (2006) Use of etanercept in the treatment of dermatomyositis: a case series. J Rheumatol 33: 1802\u20131804","journal-title":"J Rheumatol"},{"key":"226_CR27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","volume":"94","author":"Joffe","year":"1993","unstructured":"Joffe MM, Love LA, Leff RL et al. (1993) Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 94: 379\u2013387","journal-title":"Am J Med"},{"key":"226_CR28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0190-9622(97)70327-X","volume":"36","author":"Kasteler","year":"1997","unstructured":"Kasteler JS, Callen JP (1997) Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol 36: 67\u201371","journal-title":"J Am Acad Dermatol"},{"key":"226_CR29","first-page":"1369","volume":"32","author":"Lambotte","year":"2005","unstructured":"Lambotte O, Kotb R, Maigne G et al. (2005) Efficacy of rituximab in refractory polymyositis. J Rheumatol 32: 1369\u20131370","journal-title":"J Rheumatol"},{"key":"226_CR30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/08916930600623874","volume":"39","author":"Lange","year":"2006","unstructured":"Lange U, Piegsa M, Muller-Ladner U, Strunk J (2006) Anti-Jo-1 antibody positive polymyositis \u2013 successful therapy with leflunomide. Autoimmunity 39: 261\u2013264","journal-title":"Autoimmunity"},{"key":"226_CR31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.transci.2007.01.008","volume":"36","author":"Le","year":"2007","unstructured":"Le Guern V, Guillevin L (2007) Therapeutic apheresis for myositises. Transfus Apher Sci 36: 169\u2013172","journal-title":"Transfus Apher Sci"},{"key":"226_CR32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"Levine","year":"2005","unstructured":"Levine TD (2005) Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 52: 601\u2013607","journal-title":"Arthritis Rheum"},{"key":"226_CR33","doi-asserted-by":"crossref","unstructured":"Majithia V, Harisdangkul V (2005) Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy. Rheumatology (Oxford) 44: 386\u2013389","DOI":"10.1093\/rheumatology\/keh499"},{"key":"226_CR34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"Mastaglia","year":"2002","unstructured":"Mastaglia FL, Phillps BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 28: 723\u2013741","journal-title":"Rheum Dis Clin North Am"},{"key":"226_CR35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.10313","volume":"27","author":"Mastaglia","year":"2003","unstructured":"Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ (2003) Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 27: 407\u2013425","journal-title":"Muscle Nerve"},{"key":"226_CR36","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199205213262102","volume":"326","author":"Miller","year":"1992","unstructured":"Miller FW, Leitman SF, Cronin ME et al. (1992) Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 326: 1380\u20131384","journal-title":"N Engl J Med"},{"key":"226_CR37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","volume":"73","author":"Miller","year":"2002","unstructured":"Miller T, Al-Lozi MT, Lopate G, Pestronk A (2002) Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 73: 420\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"226_CR38","first-page":"1021","volume":"33","author":"Noss","year":"2006","unstructured":"Noss EH, Hausner-Sypek DL, Weinblatt ME (2006) Rituximab as therapy for refractory polymyositis and dermatomyositis. J Rheumatol 33: 1021\u20131026","journal-title":"J Rheumatol"},{"key":"226_CR39","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","volume":"353","author":"Oddis","year":"1999","unstructured":"Oddis CV, Sciurba FC, Elmagd KA, Starzl TE (1999) Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 353: 1762\u20131763","journal-title":"Lancet"},{"key":"226_CR40","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/art.21291","volume":"52","author":"Oddis","year":"2005","unstructured":"Oddis CV, Rider LG, Reed AM et al. International Myositis Assessment and Clinical Studies Group (2005) International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum 52: 2607\u20132615","journal-title":"Arthritis Rheum"},{"key":"226_CR41","doi-asserted-by":"crossref","unstructured":"Pisoni CN, Cuadrado MJ, Khamashta MA et al. (2007) Mycophenolate mofetil treatment in resistant myositis. Rheumatology (Oxford) 46: 516\u2013518","DOI":"10.1093\/rheumatology\/kel336"},{"key":"226_CR42","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1668::AID-MUS7>3.0.CO;2-#","volume":"21","author":"Phillips","year":"1998","unstructured":"Phillips BA, Zilko P, Garlepp MJ, Mastaglia FL (1998) Frequency of relapses in patients with polymyositis and dermatomyositis. Muscle Nerve 21: 1668\u20131672","journal-title":"Muscle Nerve"},{"key":"226_CR43","first-page":"2855","volume":"27","author":"Qushmaq","year":"2000","unstructured":"Qushmaq KA, Chalmers A, Esdaile JM (2000) Cyclosporin A in the treatment of refractory adult polymyositis\/dermatomyositis: population based experience in 6 patients and literature review. J Rheumatol 27: 2855\u20132859","journal-title":"J Rheumatol"},{"key":"226_CR44","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/art.20349","volume":"50","author":"Rider","year":"2004","unstructured":"Rider LG, Giannini EH, Brunner HI et al. International Myositis Assessment and Clinical Studies Group (2004) International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 50: 2281\u20132290","journal-title":"Arthritis Rheum"},{"key":"226_CR45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/mus.10026","volume":"25","author":"Schneider","year":"2002","unstructured":"Schneider C, Gold R, Sch\u00e4fers M, Toyka KV (2002) Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome. Muscle Nerve 25: 286\u2013288","journal-title":"Muscle Nerve"},{"key":"226_CR46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/mus.20543","volume":"34","author":"Schneider-Gold","year":"2006","unstructured":"Schneider-Gold C, Hartung HP, Gold R (2006) Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases. Muscle Nerve 34: 284\u2013291","journal-title":"Muscle Nerve"},{"key":"226_CR47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00002281-199811000-00008","volume":"10","author":"Spiera","year":"1998","unstructured":"Spiera R, Kagen L (1998) Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol 10: 556\u2013561","journal-title":"Curr Opin Rheumatol"},{"key":"226_CR48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","volume":"41","author":"Villalba","year":"1998","unstructured":"Villalba L, Hicks JE, Adams EM et al. (1998) Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis Rheum 41: 392\u2013399","journal-title":"Arthritis Rheum"},{"key":"226_CR49","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00002281-199611000-00008","volume":"8","author":"Villalba","year":"1996","unstructured":"Villalba L, Adams EM (1996) Update on therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol 8: 544\u2013551","journal-title":"Curr Opin Rheumatol"},{"key":"226_CR50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","volume":"29","author":"Vencovsky","year":"2000","unstructured":"Vencovsky J, Jarosova K, Machacek S et al. (2000) Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 29: 95\u2013102","journal-title":"Scand J Rheumatol"},{"key":"226_CR51","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/art.21240","volume":"52","author":"Wilkes","year":"2005","unstructured":"Wilkes MR, Sereika SM, Fertig N et al. (2005) Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 52: 2439\u20132446","journal-title":"Arthritis Rheum"},{"key":"226_CR52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0190-9622(84)80263-7","volume":"10","author":"Woo","year":"1984","unstructured":"Woo TY, Callen JP, Voorhees JJ et al. (1984) Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol 10: 592\u2013600","journal-title":"J Am Acad Dermatol"},{"key":"226_CR53","doi-asserted-by":"crossref","unstructured":"Yamasaki Y, Yamada H, Yamasaki M et al. (2007) Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis. Rheumatology (Oxford) 46: 124\u2013130","DOI":"10.1093\/rheumatology\/kel112"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0226-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-007-0226-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0226-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:29:40Z","timestamp":1559046580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-007-0226-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,14]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1007\/s00393-007-0226-9","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,14]]}}}